Viewing Study NCT06734533


Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2025-12-31 @ 5:57 PM
Study NCT ID: NCT06734533
Status: RECRUITING
Last Update Posted: 2024-12-16
First Post: 2024-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive(HR+) Metastatic Breast Cancer(MBC) .
Sponsor: Hunan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module